25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TSVT (2Seventy Bio Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze 2Seventy Bio Inc together

I guess you are interested in 2Seventy Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – 2Seventy Bio Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – 2Seventy Bio Inc’s Price Targets

I'm going to help you getting a better view of 2Seventy Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about 2Seventy Bio Inc

I send you an email if I find something interesting about 2Seventy Bio Inc.

1. Quick Overview

1.1. Quick analysis of 2Seventy Bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of 2Seventy Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.00
Expected worth in 1 year
$4.11
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$0.11
Return On Investment
2.1%

For what price can you sell your share?

Current Price per Share
$5.00
Expected price per share
$4.99 - $5.01
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of 2Seventy Bio Inc (5 min.)




Live pricePrice per Share (EOD)
$5.00
Intrinsic Value Per Share
$36.75 - $45.55
Total Value Per Share
$40.75 - $49.55

2.2. Growth of 2Seventy Bio Inc (5 min.)




Is 2Seventy Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$213.9m$284.1m-$62.2m-28.0%

How much money is 2Seventy Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$55.8m$54.7m5,355.1%
Net Profit Margin-115.2%-416.9%--

How much money comes from the company's main activities?

2.3. Financial Health of 2Seventy Bio Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#240 / 874

Most Revenue
#271 / 874

Most Profit
#246 / 874

Most Efficient
#532 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of 2Seventy Bio Inc?

Welcome investor! 2Seventy Bio Inc's management wants to use your money to grow the business. In return you get a share of 2Seventy Bio Inc.

First you should know what it really means to hold a share of 2Seventy Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of 2Seventy Bio Inc is $5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of 2Seventy Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in 2Seventy Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.00. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.91 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of 2Seventy Bio Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.010.2%-0.02-0.5%-1.05-21.0%-0.69-13.9%-0.90-17.9%-0.84-16.8%
Usd Book Value Change Per Share0.040.9%0.030.5%-0.91-18.2%-0.37-7.3%0.204.0%0.193.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.040.9%0.030.5%-0.91-18.2%-0.37-7.3%0.204.0%0.193.8%
Usd Price Per Share4.94-4.11-5.92-7.29-6.51-6.20-
Price to Earnings Ratio136.91-32.68--1.57-9.25-5.14-4.89-
Price-to-Total Gains Ratio112.60-97.72--7.43-25.31-22.67-22.67-
Price to Book Ratio1.23-0.99-1.10-1.30-1.07-1.02-
Price-to-Total Gains Ratio112.60-97.72--7.43-25.31-22.67-22.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5
Number of shares200
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.20
Usd Total Gains Per Share0.030.20
Gains per Quarter (200 shares)5.3640.04
Gains per Year (200 shares)21.43160.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1021110160150
2043320320310
3064530481470
4086740641630
50107950801790
601291160961950
70150137011211110
80171158012811270
90193179014421430
100214200016021590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%3.017.00.015.0%4.017.00.019.0%4.017.00.019.0%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%7.010.03.035.0%7.010.04.033.3%7.010.04.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%7.010.03.035.0%7.010.04.033.3%7.010.04.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of 2Seventy Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0440.027+64%-0.911+2176%-0.367+936%0.200-78%0.191-77%
Book Value Per Share--4.0044.130-3%5.339-25%5.370-25%4.111-3%3.915+2%
Current Ratio--4.7974.797+0%4.141+16%4.403+9%3.047+57%2.902+65%
Debt To Asset Ratio--0.5540.552+0%0.536+3%0.533+4%0.553+0%0.527+5%
Debt To Equity Ratio--1.2431.233+1%1.172+6%1.155+8%1.375-10%1.309-5%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--168290020.000132324287.000+27%226217144.500-26%313238990.167-46%426205214.929-61%426205214.929-61%
Eps--0.009-0.023+355%-1.048+11722%-0.694+7799%-0.897+10047%-0.842+9431%
Ev To Ebitda Ratio---50.997-14.259-72%-1.171-98%-6.134-88%-3.400-93%-3.400-93%
Ev To Sales Ratio--1.8343.480-47%3.088-41%4.730-61%7.399-75%7.399-75%
Free Cash Flow Per Share---0.205-0.251+22%-0.789+284%-0.718+250%-0.819+299%-0.763+272%
Free Cash Flow To Equity Per Share---0.196-0.248+27%-0.786+301%-0.524+167%-0.107-45%-0.102-48%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--45.546----------
Intrinsic Value_10Y_min--36.751----------
Intrinsic Value_1Y_max---1.800----------
Intrinsic Value_1Y_min---1.772----------
Intrinsic Value_3Y_max---0.558----------
Intrinsic Value_3Y_min---0.630----------
Intrinsic Value_5Y_max--6.531----------
Intrinsic Value_5Y_min--5.645----------
Market Cap266141500.000+1%263959020.000220870037.000+20%314845394.500-16%388468740.167-32%346697050.450-24%330187667.095-20%
Net Profit Margin--0.021-1.152+5584%-4.169+19939%-2.791+13381%-4.017+19216%-3.819+18276%
Operating Margin---0.107-2.816+2522%-3.886+3519%-3.277+2952%-4.476+4069%-4.260+3867%
Operating Ratio--1.1103.794-71%4.901-77%4.275-74%5.491-80%5.271-79%
Pb Ratio1.249+1%1.2340.995+24%1.102+12%1.300-5%1.071+15%1.020+21%
Pe Ratio138.571+1%136.90832.677+319%-1.570+101%9.253+1380%5.140+2564%4.895+2697%
Price Per Share5.000+1%4.9404.113+20%5.915-16%7.286-32%6.506-24%6.196-20%
Price To Free Cash Flow Ratio-6.087-1%-6.014-4.596-24%-2.095-65%-3.126-48%-2.314-62%-2.204-63%
Price To Total Gains Ratio113.963+1%112.59697.721+15%-7.434+107%25.312+345%22.670+397%22.670+397%
Quick Ratio--6.5787.038-7%6.376+3%6.486+1%4.422+49%4.211+56%
Return On Assets--0.001-0.003+383%-0.094+9436%-0.056+5679%-0.098+9858%-0.093+9394%
Return On Equity--0.002-0.007+410%-0.206+9253%-0.121+5449%-0.352+15726%-0.320+14287%
Total Gains Per Share--0.0440.027+64%-0.911+2176%-0.367+936%0.200-78%0.191-77%
Usd Book Value--213961000.000221918250.000-4%284164000.000-25%286523583.333-25%219253050.000-2%208812428.571+2%
Usd Book Value Change Per Share--0.0440.027+64%-0.911+2176%-0.367+936%0.200-78%0.191-77%
Usd Book Value Per Share--4.0044.130-3%5.339-25%5.370-25%4.111-3%3.915+2%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--168290020.000132324287.000+27%226217144.500-26%313238990.167-46%426205214.929-61%426205214.929-61%
Usd Eps--0.009-0.023+355%-1.048+11722%-0.694+7799%-0.897+10047%-0.842+9431%
Usd Free Cash Flow---10973000.000-13547250.000+23%-42011250.000+283%-38310666.667+249%-43635950.000+298%-40668571.429+271%
Usd Free Cash Flow Per Share---0.205-0.251+22%-0.789+284%-0.718+250%-0.819+299%-0.763+272%
Usd Free Cash Flow To Equity Per Share---0.196-0.248+27%-0.786+301%-0.524+167%-0.107-45%-0.102-48%
Usd Market Cap266141500.000+1%263959020.000220870037.000+20%314845394.500-16%388468740.167-32%346697050.450-24%330187667.095-20%
Usd Price Per Share5.000+1%4.9404.113+20%5.915-16%7.286-32%6.506-24%6.196-20%
Usd Profit--482000.000-1023000.000+312%-55805500.000+11678%-36482666.667+7669%-47271550.000+9907%-44335761.905+9298%
Usd Revenue--22938000.00012091250.000+90%17800250.000+29%20354500.000+13%22271600.000+3%26443952.381-13%
Usd Total Gains Per Share--0.0440.027+64%-0.911+2176%-0.367+936%0.200-78%0.191-77%
 EOD+5 -3MRQTTM+26 -11YOY+23 -143Y+24 -135Y+18 -1910Y+20 -17

3.3 Fundamental Score

Let's check the fundamental score of 2Seventy Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15138.571
Price to Book Ratio (EOD)Between0-11.249
Net Profit Margin (MRQ)Greater than00.021
Operating Margin (MRQ)Greater than0-0.107
Quick Ratio (MRQ)Greater than16.578
Current Ratio (MRQ)Greater than14.797
Debt to Asset Ratio (MRQ)Less than10.554
Debt to Equity Ratio (MRQ)Less than11.243
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.001
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of 2Seventy Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.250
Ma 20Greater thanMa 504.996
Ma 50Greater thanMa 1004.973
Ma 100Greater thanMa 2003.838
OpenGreater thanClose5.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About 2Seventy Bio Inc

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-29 20:39:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ 2Seventy Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 2.1%Β means thatΒ $0.02 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 2Seventy Bio Inc:

  • The MRQ is 2.1%. The company is making a profit. +1
  • The TTM is -115.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ2.1%TTM-115.2%+117.3%
TTM-115.2%YOY-416.9%+301.6%
TTM-115.2%5Y-401.7%+286.4%
5Y-401.7%10Y-381.9%-19.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-92.7%+94.8%
TTM-115.2%-140.3%+25.1%
YOY-416.9%-196.4%-220.5%
3Y-279.1%-248.5%-30.6%
5Y-401.7%-343.4%-58.3%
10Y-381.9%-496.2%+114.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ 2Seventy Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • 0.1% Return on Assets means thatΒ 2Seventy Bio Inc generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 2Seventy Bio Inc:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-0.3%+0.4%
TTM-0.3%YOY-9.4%+9.1%
TTM-0.3%5Y-9.8%+9.5%
5Y-9.8%10Y-9.3%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-11.6%+11.7%
TTM-0.3%-11.6%+11.3%
YOY-9.4%-11.4%+2.0%
3Y-5.6%-11.8%+6.2%
5Y-9.8%-12.0%+2.2%
10Y-9.3%-13.7%+4.4%
4.3.1.3. Return on Equity

Shows how efficient 2Seventy Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • 0.2% Return on Equity means 2Seventy Bio Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 2Seventy Bio Inc:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-0.7%+0.9%
TTM-0.7%YOY-20.6%+19.9%
TTM-0.7%5Y-35.2%+34.5%
5Y-35.2%10Y-32.0%-3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-13.6%+13.8%
TTM-0.7%-15.0%+14.3%
YOY-20.6%-14.5%-6.1%
3Y-12.1%-16.9%+4.8%
5Y-35.2%-17.5%-17.7%
10Y-32.0%-19.9%-12.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of 2Seventy Bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient 2Seventy Bio Inc is operatingΒ .

  • Measures how much profit 2Seventy Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of -10.7%Β means the company generated $-0.11 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 2Seventy Bio Inc:

  • The MRQ is -10.7%. The company is operating very inefficient. -2
  • The TTM is -281.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-281.6%+270.8%
TTM-281.6%YOY-388.6%+107.0%
TTM-281.6%5Y-447.6%+166.1%
5Y-447.6%10Y-426.0%-21.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.7%-229.2%+218.5%
TTM-281.6%-249.0%-32.6%
YOY-388.6%-208.5%-180.1%
3Y-327.7%-223.8%-103.9%
5Y-447.6%-346.1%-101.5%
10Y-426.0%-475.5%+49.5%
4.3.2.2. Operating Ratio

Measures how efficient 2Seventy Bio Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 1.11 means that the operating costs are $1.11 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 1.110. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.794. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.110TTM3.794-2.684
TTM3.794YOY4.901-1.107
TTM3.7945Y5.491-1.698
5Y5.49110Y5.271+0.220
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1102.110-1.000
TTM3.7942.684+1.110
YOY4.9013.096+1.805
3Y4.2753.652+0.623
5Y5.4914.745+0.746
10Y5.2716.614-1.343
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of 2Seventy Bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if 2Seventy Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.80Β means the company has $4.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 4.797. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.797. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.797TTM4.797+0.000
TTM4.797YOY4.141+0.655
TTM4.7975Y3.047+1.750
5Y3.04710Y2.902+0.145
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7973.661+1.136
TTM4.7973.846+0.951
YOY4.1414.140+0.001
3Y4.4034.688-0.285
5Y3.0475.746-2.699
10Y2.9026.147-3.245
4.4.3.2. Quick Ratio

Measures if 2Seventy Bio Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 6.58Β means the company can pay off $6.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 6.578. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.038. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.578TTM7.038-0.460
TTM7.038YOY6.376+0.662
TTM7.0385Y4.422+2.616
5Y4.42210Y4.211+0.211
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5782.826+3.752
TTM7.0383.182+3.856
YOY6.3763.786+2.590
3Y6.4864.311+2.175
5Y4.4225.703-1.281
10Y4.2116.454-2.243
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of 2Seventy Bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of 2Seventy Bio IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ 2Seventy Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.55Β means that 2Seventy Bio Inc assets areΒ financed with 55.4% credit (debt) and the remaining percentage (100% - 55.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 0.554. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.552. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.554TTM0.552+0.002
TTM0.552YOY0.536+0.016
TTM0.5525Y0.553-0.001
5Y0.55310Y0.527+0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5540.329+0.225
TTM0.5520.349+0.203
YOY0.5360.331+0.205
3Y0.5330.340+0.193
5Y0.5530.349+0.204
10Y0.5270.379+0.148
4.5.4.2. Debt to Equity Ratio

Measures ifΒ 2Seventy Bio Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 124.3% means that company has $1.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 1.243. The company is able to pay all its debts with equity. +1
  • The TTM is 1.233. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.243TTM1.233+0.010
TTM1.233YOY1.172+0.061
TTM1.2335Y1.375-0.141
5Y1.37510Y1.309+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2430.379+0.864
TTM1.2330.437+0.796
YOY1.1720.414+0.758
3Y1.1550.450+0.705
5Y1.3750.464+0.911
10Y1.3090.515+0.794
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings 2Seventy Bio Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ 2Seventy Bio Inc to theΒ Biotechnology industry mean.
  • A PE ratio of 136.91 means the investor is paying $136.91Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 2Seventy Bio Inc:

  • The EOD is 138.571. Based on the earnings, the company is expensive. -2
  • The MRQ is 136.908. Based on the earnings, the company is expensive. -2
  • The TTM is 32.677. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD138.571MRQ136.908+1.663
MRQ136.908TTM32.677+104.231
TTM32.677YOY-1.570+34.247
TTM32.6775Y5.140+27.538
5Y5.14010Y4.895+0.245
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD138.571-2.304+140.875
MRQ136.908-2.080+138.988
TTM32.677-2.564+35.241
YOY-1.570-3.764+2.194
3Y9.253-3.773+13.026
5Y5.140-6.193+11.333
10Y4.895-6.833+11.728
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of 2Seventy Bio Inc:

  • The EOD is -6.087. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.014. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.596. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.087MRQ-6.014-0.073
MRQ-6.014TTM-4.596-1.418
TTM-4.596YOY-2.095-2.501
TTM-4.5965Y-2.314-2.282
5Y-2.31410Y-2.204-0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.087-3.132-2.955
MRQ-6.014-2.705-3.309
TTM-4.596-3.666-0.930
YOY-2.095-4.405+2.310
3Y-3.126-5.059+1.933
5Y-2.314-8.477+6.163
10Y-2.204-9.304+7.100
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ 2Seventy Bio Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.23 means the investor is paying $1.23Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 2Seventy Bio Inc:

  • The EOD is 1.249. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.234. Based on the equity, the company is underpriced. +1
  • The TTM is 0.995. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.249MRQ1.234+0.015
MRQ1.234TTM0.995+0.239
TTM0.995YOY1.102-0.108
TTM0.9955Y1.071-0.076
5Y1.07110Y1.020+0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2491.953-0.704
MRQ1.2341.843-0.609
TTM0.9952.112-1.117
YOY1.1022.441-1.339
3Y1.3002.494-1.194
5Y1.0713.661-2.590
10Y1.0204.311-3.291
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of 2Seventy Bio Inc.

4.8.1. Institutions holding 2Seventy Bio Inc

Institutions are holding 82.403% of the shares of 2Seventy Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Goldman Sachs Group Inc8.79520.003746816753867749.0054
2025-03-31Beryl Capital Management LLC7.98437.8439425000042500000
2025-03-31BlackRock Inc7.46170.00043971873-250781-5.9389
2025-03-31Morgan Stanley - Brokerage Accounts5.57410.00112967078491941.6859
2025-03-31Vanguard Group Inc5.29680.00032819469-941776-25.0389
2025-03-31Newtyn Management LLC4.76211.9811253483600
2025-03-31Bank of America Corp4.72760.00125165056080.0242
2025-03-31Baker Bros Advisors LP4.6920.1365249752600
2025-03-31Man Group PLC3.83810.0256204302620430260
2025-03-31Casdin Capital, LLC3.75730.8073200000000
2025-03-31Glazer Capital, LLC2.49520.3036132816613281660
2025-03-31Regeneron Pharmaceuticals Inc2.35740.5022125482700
2025-03-31Geode Capital Management, LLC2.26820.00051207345330842.8174
2025-03-31First Trust Capital Management L.P.2.14910.4085114396211439620
2025-03-31State Street Corp2.00980.00021069815-7838-0.7273
2025-03-31The Toronto-Dominion Bank1.50290.007780000000
2025-03-31Engine Capital Management LP1.32250.659170397200
2025-03-31Madison Avenue Partners, LP1.08940.243257989500
2025-03-31HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.86420.004946000018000064.2857
2025-03-31Dafna Capital Management LLC0.80640.601342925200
Total 73.754313.532139259222+8214419+20.9%

4.9.2. Funds holding 2Seventy Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Fidelity Small Cap Index0.91510.0148709954621.134
2025-04-30Fidelity Extended Market Index0.5310.0039282635-2702-0.947
2025-03-31Stork Fund Dynamic MultiStrategies O EUR0.48040.09932557142557140
2024-11-30Galileo - Biotech Innovation Fund S USD0.27561.553214670000
2025-03-31NT R2000 Index Fund - NL0.22290.010111863953134.6882
2025-03-31Extended Equity Market Fund K0.19920.0041060403250.3074
2025-04-30Fidelity Total Market Index0.18290.00059737600
2025-03-31NT R2000 Index Fund - DC - NL - 30.17810.01019477723242.5137
2025-03-31GDL Fund0.15970.343185000850000
2025-03-31Russell 2500β„’ Index Fund F0.15090.004180336-17-0.0212
2025-04-30Fidelity Series Total Market Index0.13640.00057259631824.5841
2025-03-31Russell 2000 Index Non-Lendable Fund E0.12380.009965882-5368-7.534
2025-03-31Northern Trust Extended Eq Market Idx0.1150.00396122827304.6668
2025-03-31NT Ext Equity Mkt Idx Fd - L0.1150.00386122827304.6668
2025-04-30Spartan Extended Market Index Pool F0.10910.00395807727024.8795
2025-04-30EQ/2000 Managed Volatility IB0.10680.00925683800
2025-03-31NT Col R2000 Val Idx Fd -DC -L -TierFour0.10330.020154970-47334-46.268
2025-03-31Northern Trust Russell 2000 Value Index0.10330.020454970-47334-46.268
2025-03-31Fidelity Small Cap Value Index0.09880.02025257737137.5986
2025-04-30Nuveen Small Cap Blend Idx R60.09570.008650936-17113-25.1481
Total 4.4032.13882343618+249327+10.6%

5.3. Insider Transactions

Insiders are holding 6.438% of the shares of 2Seventy Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-17Jessica SnowSELL22984.95
2025-03-17Victoria EatwellSELL25924.95
2025-03-17William D Baird IiiSELL50924.95
2025-03-11Global Healthcare Master KynamSELL51421114.93
2024-12-13Jessica SnowSELL22873.23
2024-11-18Marcela V MausSELL39003.38
2024-08-14Jessica SnowSELL78164.32
2024-08-05Victoria EatwellSELL133.98
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets480,005
Total Liabilities266,044
Total Stockholder Equity213,961
 As reported
Total Liabilities 266,044
Total Stockholder Equity+ 213,961
Total Assets = 480,005

Assets

Total Assets480,005
Total Current Assets198,582
Long-term Assets281,423
Total Current Assets
Cash And Cash Equivalents 92,356
Short-term Investments 78,019
Net Receivables 23,928
Other Current Assets 4,279
Total Current Assets  (as reported)198,582
Total Current Assets  (calculated)198,582
+/-0
Long-term Assets
Property Plant Equipment 232,124
Long Term Investments 2,987
Intangible Assets 5,708
Long-term Assets Other 40,604
Long-term Assets  (as reported)281,423
Long-term Assets  (calculated)281,423
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities41,397
Long-term Liabilities224,647
Total Stockholder Equity213,961
Total Current Liabilities
Short-term Debt 16,761
Accounts payable 5,176
Other Current Liabilities 19,460
Total Current Liabilities  (as reported)41,397
Total Current Liabilities  (calculated)41,397
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt223,002
Long-term Liabilities Other 1,645
Long-term Liabilities  (as reported)224,647
Long-term Liabilities  (calculated)224,647
+/-0
Total Stockholder Equity
Common Stock5
Retained Earnings -567,982
Accumulated Other Comprehensive Income 54
Other Stockholders Equity 781,884
Total Stockholder Equity (as reported)213,961
Total Stockholder Equity (calculated)213,961
+/-0
Other
Capital Stock5
Cash and Short Term Investments 170,375
Common Stock Shares Outstanding 53,433
Liabilities and Stockholders Equity 480,005
Net Debt 147,407
Net Invested Capital 213,961
Net Working Capital 157,185
Property Plant and Equipment Gross 263,622
Short Long Term Debt Total 239,763



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
303,744
0
0
0
312,620
0
303,744
192,959
759,675
851,921
787,406
708,744
656,665
742,437
705,713
640,806
565,426
511,051
517,896
503,846
479,510
480,005
480,005479,510503,846517,896511,051565,426640,806705,713742,437656,665708,744787,406851,921759,675192,959303,7440312,620000303,744
   > Total Current Assets 
18,625
0
0
25,104
25,104
18,625
18,625
24,595
291,564
412,799
383,890
349,417
300,882
389,817
333,665
277,254
237,765
212,842
224,871
218,479
187,256
198,582
198,582187,256218,479224,871212,842237,765277,254333,665389,817300,882349,417383,890412,799291,56424,59518,62518,62525,10425,1040018,625
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
130,414
270,893
269,868
127,021
71,032
193,629
95,991
90,226
74,958
56,792
111,864
59,984
71,244
92,356
92,35671,24459,984111,86456,79274,95890,22695,991193,62971,032127,021269,868270,893130,41400000000
       Short-term Investments 
0
0
0
0
0
0
0
0
134,643
106,973
88,059
196,089
195,238
146,301
186,846
160,393
142,031
124,590
90,009
132,415
103,510
78,019
78,019103,510132,41590,009124,590142,031160,393186,846146,301195,238196,08988,059106,973134,64300000000
       Net Receivables 
11,370
0
0
10,691
10,691
11,370
11,370
16,135
16,995
16,931
12,161
12,037
20,960
41,252
44,099
19,515
13,411
11,977
18,125
22,275
7,781
23,928
23,9287,78122,27518,12511,97713,41119,51544,09941,25220,96012,03712,16116,93116,99516,13511,37011,37010,69110,6910011,370
       Other Current Assets 
7,255
0
0
0
14,413
0
14,510
8,460
9,512
18,002
13,802
14,270
13,652
49,887
50,828
7,120
7,365
19,483
4,873
3,805
4,721
4,279
4,2794,7213,8054,87319,4837,3657,12050,82849,88713,65214,27013,80218,0029,5128,46014,510014,4130007,255
   > Long-term Assets 
285,119
0
0
0
287,516
0
285,119
168,364
468,111
439,122
403,516
359,327
355,783
352,620
372,048
363,552
327,661
298,209
293,025
285,367
292,254
281,423
281,423292,254285,367293,025298,209327,661363,552372,048352,620355,783359,327403,516439,122468,111168,364285,1190287,516000285,119
       Property Plant Equipment 
241,379
0
0
260,481
260,481
253,944
253,944
139,062
310,447
305,863
304,139
300,108
296,620
294,417
291,735
285,234
278,108
253,551
247,179
240,961
238,150
232,124
232,124238,150240,961247,179253,551278,108285,234291,735294,417296,620300,108304,139305,863310,447139,062253,944253,944260,481260,48100241,379
       Goodwill 
13,128
0
0
0
13,128
0
13,128
12,056
12,056
12,056
12,056
12,056
12,056
12,056
12,056
12,056
0
0
0
0
0
0
00000012,05612,05612,05612,05612,05612,05612,05612,05612,05613,128013,12800013,128
       Long Term Investments 
0
0
0
0
0
0
0
0
97,124
74,683
40,639
1,407
1,414
1,432
23,709
33,659
4,816
0
0
0
8,867
2,987
2,9878,8670004,81633,65923,7091,4321,4141,40740,63974,68397,12400000000
       Intangible Assets 
12,127
0
0
0
5,644
0
12,127
11,009
9,892
8,774
7,656
7,479
7,302
7,125
6,948
6,771
6,594
6,417
6,240
6,063
5,885
5,708
5,7085,8856,0636,2406,4176,5946,7716,9487,1257,3027,4797,6568,7749,89211,00912,12705,64400012,127
       Long-term Assets Other 
18,485
0
0
0
8,263
0
5,920
6,237
38,592
37,746
39,026
38,277
38,391
37,590
37,600
37,888
38,143
38,241
39,606
38,343
39,352
40,604
40,60439,35238,34339,60638,24138,14337,88837,60037,59038,39138,27739,02637,74638,5926,2375,92008,26300018,485
> Total Liabilities 
255,055
0
0
0
237,991
0
255,055
251,366
399,853
404,505
408,422
385,564
346,199
341,113
338,218
334,384
310,126
303,612
283,092
275,744
268,704
266,044
266,044268,704275,744283,092303,612310,126334,384338,218341,113346,199385,564408,422404,505399,853251,366255,0550237,991000255,055
   > Total Current Liabilities 
103,783
0
0
75,868
75,868
103,783
103,783
106,080
98,388
106,313
99,014
79,897
79,794
76,929
66,895
68,008
59,779
60,406
47,204
44,095
40,092
41,397
41,39740,09244,09547,20460,40659,77968,00866,89576,92979,79479,89799,014106,31398,388106,080103,783103,78375,86875,86800103,783
       Short-term Debt 
14,100
0
0
0
15,313
0
14,100
28,960
19,538
20,132
21,460
21,596
11,164
11,482
11,872
12,267
25,320
13,006
15,507
15,797
16,365
16,761
16,76116,36515,79715,50713,00625,32012,26711,87211,48211,16421,59621,46020,13219,53828,96014,100015,31300014,100
       Accounts payable 
18,978
0
0
7,152
7,152
18,978
18,978
6,197
6,024
13,647
6,685
7,983
7,208
13,399
6,274
5,307
6,028
8,801
2,995
5,076
1,055
5,176
5,1761,0555,0762,9958,8016,0285,3076,27413,3997,2087,9836,68513,6476,0246,19718,97818,9787,1527,1520018,978
       Other Current Liabilities 
44,943
0
0
14,407
52,583
17,407
70,705
70,923
67,826
67,534
70,869
50,318
58,422
43,568
36,107
37,408
13,028
22,263
27,814
22,765
22,672
19,460
19,46022,67222,76527,81422,26313,02837,40836,10743,56858,42250,31870,86967,53467,82670,92370,70517,40752,58314,4070044,943
   > Long-term Liabilities 
151,272
0
0
0
162,123
0
151,272
145,286
301,465
298,192
309,408
305,667
266,405
264,184
271,323
266,376
250,347
243,206
235,888
231,649
228,612
224,647
224,647228,612231,649235,888243,206250,347266,376271,323264,184266,405305,667309,408298,192301,465145,286151,2720162,123000151,272
       Other Liabilities 
0
0
0
49,833
49,833
47,197
47,197
45,467
29,019
28,903
43,496
43,177
7,397
0
0
0
0
0
0
0
0
0
0000000007,39743,17743,49628,90329,01945,46747,19747,19749,83349,833000
> Total Stockholder Equity
43,692
43,692
0
0
74,629
74,629
48,689
-58,407
359,822
447,416
378,984
323,180
310,466
401,324
367,495
306,422
255,300
207,439
234,804
228,102
210,806
213,961
213,961210,806228,102234,804207,439255,300306,422367,495401,324310,466323,180378,984447,416359,822-58,40748,68974,62974,6290043,69243,692
   Common Stock
0
0
0
74,629
74,629
48,689
48,689
-58,407
2
4
4
4
4
5
5
5
5
5
5
5
5
5
55555555544442-58,40748,68948,68974,62974,629000
   Retained Earnings Total Equity0000000-382,757-340,668-293,647-270,504-202,625-125,205-39,49400000000
   Accumulated Other Comprehensive Income 
0
43,692
0
0
0
74,629
0
-58,407
-712
-2,804
-3,382
-3,886
-2,877
-1,950
-1,430
-916
-204
-336
-236
305
89
54
5489305-236-336-204-916-1,430-1,950-2,877-3,886-3,382-2,804-712-58,407074,62900043,6920
   Capital Surplus 
0
0
0
0
0
0
0
0
400,026
575,421
584,987
597,566
606,986
743,937
751,677
0
0
0
0
0
0
0
0000000751,677743,937606,986597,566584,987575,421400,02600000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
43,692
0
0
0
74,629
0
48,689
-58,407
400,026
575,421
584,987
597,566
606,986
743,937
751,677
761,728
766,716
771,660
774,046
776,736
779,176
781,884
781,884779,176776,736774,046771,660766,716761,728751,677743,937606,986597,566584,987575,421400,026-58,40748,689074,62900043,692



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue37,862
Cost of Revenue-22,563
Gross Profit15,29915,299
 
Operating Income (+$)
Gross Profit15,299
Operating Expense-130,729
Operating Income-115,430-115,430
 
Operating Expense (+$)
Research Development76,917
Selling General Administrative43,924
Selling And Marketing Expenses0
Operating Expense130,729120,841
 
Net Interest Income (+$)
Interest Income10,875
Interest Expense-0
Other Finance Cost-0
Net Interest Income10,875
 
Pretax Income (+$)
Operating Income-115,430
Net Interest Income10,875
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-57,247-173,613
EBIT - interestExpense = -105,542
-57,247
-57,247
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-105,542-57,247
Earnings Before Interest and Taxes (EBITDA)-98,446
 
After tax Income (+$)
Income Before Tax-57,247
Tax Provision-0
Net Income From Continuing Ops-57,247-57,247
Net Income-57,247
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses153,292
Total Other Income/Expenses Net58,183-10,875
 

Technical Analysis of 2Seventy Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of 2Seventy Bio Inc. The general trend of 2Seventy Bio Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine 2Seventy Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. 2Seventy Bio Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of 2Seventy Bio Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.01 < 5.01 < 5.01.

The bearish price targets are: 4.99 > 4.99 > 4.99.

Know someone who trades $TSVT? Share this with them.πŸ‘‡

2Seventy Bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of 2Seventy Bio Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

2Seventy Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of 2Seventy Bio Inc. The current macd is 0.04948959.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 2Seventy Bio Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for 2Seventy Bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the 2Seventy Bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
2Seventy Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart2Seventy Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of 2Seventy Bio Inc. The current adx is 54.49.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy 2Seventy Bio Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
2Seventy Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of 2Seventy Bio Inc. The current sar is 4.9864585.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
2Seventy Bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of 2Seventy Bio Inc. The current rsi is 72.25. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
2Seventy Bio Inc Daily Relative Strength Index (RSI) Chart2Seventy Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of 2Seventy Bio Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -3/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the 2Seventy Bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
2Seventy Bio Inc Daily Stochastic Oscillator Chart2Seventy Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of 2Seventy Bio Inc. The current cci is 61.86.

2Seventy Bio Inc Daily Commodity Channel Index (CCI) Chart2Seventy Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of 2Seventy Bio Inc. The current cmo is 31.24.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
2Seventy Bio Inc Daily Chande Momentum Oscillator (CMO) Chart2Seventy Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of 2Seventy Bio Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that 2Seventy Bio Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
2Seventy Bio Inc Daily Williams %R Chart2Seventy Bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of 2Seventy Bio Inc.

2Seventy Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of 2Seventy Bio Inc. The current atr is 0.01774592.

2Seventy Bio Inc Daily Average True Range (ATR) Chart2Seventy Bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of 2Seventy Bio Inc. The current obv is 48,036,942.

2Seventy Bio Inc Daily On-Balance Volume (OBV) Chart2Seventy Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of 2Seventy Bio Inc. The current mfi is 60.39.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
2Seventy Bio Inc Daily Money Flow Index (MFI) Chart2Seventy Bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for 2Seventy Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

2Seventy Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of 2Seventy Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.250
Ma 20Greater thanMa 504.996
Ma 50Greater thanMa 1004.973
Ma 100Greater thanMa 2003.838
OpenGreater thanClose5.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of 2Seventy Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on 2Seventy Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about 2Seventy Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about 2Seventy Bio Inc

I send you an email if I find something interesting about 2Seventy Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about 2Seventy Bio Inc.

Receive notifications about 2Seventy Bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.